Loading organizations...
Key people at Abu Dhabi Growth Fund.
Key people at Abu Dhabi Growth Fund.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Apr 1, 2023 | Orbital Therapeutics | $270.0M Series A | ARCH Venture Partners | Andreessen Horowitz, Nextech Invest, Section 32, Versant Ventures, a16z Bio + Health, Agent Capital, Alexandria Venture Investments, Casdin Capital, Exor, Heritage Medical Systems, iGlobe Partners, Invus, Newpath Partners, Redmile Group, Rellim Capital Management |
| Oct 1, 2022 | Neumora Therapeutics | $110.0M Series B | — | B Capital Group, Mubadala, Rajan Anandan, Krishna Mehra, Altitude Life Science Ventures, Amgen Ventures, ARCH Venture Partners, Exor Ventures, F-Prime Capital, Invus, Alaa Halawa, Newpath Partners, Polaris Partners |
| Jan 1, 2022 | Savage X Fenty | $130.0M Series C | Neuberger Berman | H/L Ventures, Marcy Venture Partners, L Catterton, Multiply Group |
| Nov 10, 2021 | Cerebras | $250.0M Series F | Abu Dhabi Growth Fund, Rick Gerson | — |
| Nov 5, 2021 | Lime | $523.0M Debt / Other Equity | Abu Dhabi Growth Fund, Fidelity Management & Research Company, Highbridge Capital Management, Dara Khosrowshahi | UBS |